AbbVie Inc. (ABBV) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    AbbVie Inc.

    NYSE: ABBV · Real-Time Price · USD
    212.43
    -0.57 (-0.27%)
    At close: Sep 05, 2025, 11:08 AM

    AbbVie Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 56.33B 54.32B 58.05B 56.2B
    Cost of Revenue
    		 16.9B 20.41B 17.41B 17.45B
    Gross Profit
    		 39.43B 33.9B 40.64B 38.75B
    Operating Income
    		 9.14B 12.76B 18.12B 17.92B
    Interest Income
    		 648M 540M 186M 39M
    Pretax Income
    		 3.72B 6.25B 13.48B 12.99B
    Net Income
    		 4.28B 4.86B 11.84B 11.54B
    Selling & General & Admin
    		 13.19B 12.87B 15.26B 12.35B
    Research & Development
    		 12.79B 7.67B 6.51B 8.05B
    Other Expenses
    		 4.31B 599M 753M 432M
    Operating Expenses
    		 30.29B 21.15B 22.52B 20.83B
    Interest Expense
    		 2.81B 2.22B 2.23B 2.42B
    Selling & Marketing Expenses
    		 2.1B n/a 2B 2.1B
    Cost & Expenses
    		 47.2B 41.56B 39.94B 38.27B
    Income Tax Expense
    		 -570M 1.38B 1.63B 1.44B
    Shares Outstanding (Basic)
    		 1.77B 1.77B 1.77B 1.77B
    Shares Outstanding (Diluted)
    		 1.77B 1.77B 1.78B 1.78B
    EPS (Basic)
    		 2.40 2.73 6.65 6.48
    EPS (Diluted)
    		 2.39 2.72 6.63 6.45
    EBITDA
    		 14.91B 17.17B 24.17B 23.93B
    EBIT
    		 6.52B 8.47B 15.71B 15.41B
    Depreciation & Amortization
    		 8.39B 8.7B 8.47B 8.52B

    Add to Watchlist